Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease
1 Department of Physiology, Anatomy and Genetics , 2 Department of Clinical Neurology, University of Oxford and 3 Department of Neuropathology, University of Oxford, Henry Wellcome Building of Gene Function, South Parks Road, Oxford OX1 3QX, UK
* To whom correspondence should be addressed. Tel: +44 1865285875; Fax: +44 1865790493; Email: kevin.talbot{at}clneuro.ox.ac.uk
Received July 19, 2006; Accepted July 27, 2006
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease classically defined by the impairment of the voluntary motor system and ubiquitin-positive intraneuronal aggregates in anterior horn cells. Frontotemporal dementia (FTD) is a common form of neurodegenerative dementia and presents with personality change associated in a significant subgroup of patients with cortical ubiquitin-only neuropathology (FTD-U). Careful study of ALS as well as FTD patient cohorts suggests clinical as well as pathological overlap of ALS with FTD. The idea that this reflects a shared pathogenesis has received strong support from the identification of new genetic loci on chromosome 9p and of mutations in specific genes (CHMP2B and DCN1) in families with co-segregation of ALS and FTD. The identification of two further genetic causes of FTD-U with (rare) ALS (PGRN) or without ALS (VCP) also provides a starting point for exploring the pathways associated with ubiquitin-mediated protein mishandling in FTD-U and ALS. Pure ALS, through ALS with cognitive impairment and ALSFTD to pure FTD-U, may represent a continuous spectrum of ubiquitin-associated neurodegenerative disease.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K L Williams, J C Durnall, A D Thoeng, S T Warraich, G A Nicholson, and I P Blair A novel TARDBP mutation in an Australian amyotrophic lateral sclerosis kindred J. Neurol. Neurosurg. Psychiatry, November 1, 2009; 80(11): 1286 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vergarajauregui, P. S. Connelly, M. P. Daniels, and R. Puertollano Autophagic dysfunction in mucolipidosis type IV patients Hum. Mol. Genet., September 1, 2008; 17(17): 2723 - 2737. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sleegers, N. Brouwers, S. Maurer-Stroh, M. A. van Es, P. V. Damme, P.W.J. van Vught, J. van der Zee, S. Serneels, T. D. Pooter, M. Van den Broeck, et al. Progranulin genetic variability contributes to amyotrophic lateral sclerosis Neurology, July 22, 2008; 71(4): 253 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Igaz, L. K. Kwong, Y. Xu, A. C. Truax, K. Uryu, M. Neumann, C. M. Clark, L. B. Elman, B. L. Miller, M. Grossman, et al. Enrichment of C-Terminal Fragments in TAR DNA-Binding Protein-43 Cytoplasmic Inclusions in Brain but not in Spinal Cord of Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis Am. J. Pathol., July 1, 2008; 173(1): 182 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Filimonenko, S. Stuffers, C. Raiborg, A. Yamamoto, L. Malerod, E. M.C. Fisher, A. Isaacs, A. Brech, H. Stenmark, and A. Simonsen Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease J. Cell Biol., November 5, 2007; 179(3): 485 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Duffy, R. K. Peach, and E. A. Strand Progressive Apraxia of Speech as a Sign of Motor Neuron Disease Am J Speech Lang Pathol, August 1, 2007; 16(3): 198 - 208. [Abstract] [Full Text] [PDF] |
||||





